营所需的相应资质，标的资产的过户不涉及立项、环保、行业准入、用地、规划、 建设施工等有关报批事项。本次交易涉及的有关审批事项已在本报告书中详细披 露，并对本次交易无法获得批准或核准的风险作出了特别提示; 转让的情形；标的公司不存在出资不实或者影响其合法存续的情况，在相关法律 程序和先决条件得到适当履行和满足的情形下，标的资产过户至公司名下不存在 实质性法律障碍； 与关联人保持独立，符合中国证监会关于上市公司独立性的相关规定。本次交易 有利于提高公司资产的完整性，有利于公司在人员、采购、生产、销售、知识产 权等方面继续保持独立； 大不利变化；有利于上市公司突出主业、增强抗风险能力；有利于上市公司增强 独立性，不会导致新增重大不利影响的同业竞争，以及严重影响独立性或者显失 公平的关联交易。 粤开证券股份有限公司 关于本次交易符合《上市公司监管指引第 9 号——上市公 司筹划和实施重大资产重组的监管要求》第四条规定的核 查意见 美年大健康产业控股股份有限公司（以下简称"美年健康"、"上市公司"） 拟通过发行股份的方式购买衡阳美年健康体检中心有限公司84.00%股权、宁德美 年大健康管理有限公司81.00%股权、烟台 ...

Group 1 - The asset evaluation report is prepared based on the Chinese Asset Evaluation Standards and aims to assess the value of the entire equity of Wuhan Meici Aoya Technology Management Co., Ltd. for the purpose of issuing shares to purchase assets by Meinian Health Industry Holdings Co., Ltd. [1][2] - The evaluation was conducted by Jinzheng (Shanghai) Asset Evaluation Co., Ltd. using the income method and asset-based method, with a market value assessment date of March 31, 2025 [5][7]. - The assessed market value of the entire equity of the evaluated unit is RMB 83 million (8,300.00 million) as of the evaluation base date [7][28]. Group 2 - The evaluated unit, Wuhan Meici Aoya Technology Management Co., Ltd., was established in December 2017 and focuses on health check-ups, health consulting, and management services [9][10]. - The company has a registered capital of RMB 80.8276 million and operates in Wuhan, with its business scope including medical services and health consulting [9][10]. - The financial status of the evaluated unit shows total assets of RMB 56.89 million, total liabilities of RMB 37.31 million, and total equity of RMB 19.58 million as of March 31, 2025 [28][29]. Group 3 - The evaluation report indicates that the assessed unit's main assets include current assets, fixed assets, intangible assets, and other non-current assets, with fixed assets comprising 1,510 pieces of equipment valued at RMB 29.66 million [29]. - The company has established branches and offers a range of health check-up products tailored to different age groups, addressing common health issues [17][21]. - The revenue model includes income from health check-up services, with a focus on both group and individual clients, and the company aims to provide a comprehensive health management solution [24][25].

Group 1 - The Beijing Municipal Government has released 96 local standards, including 69 new and 27 revised standards, aimed at improving various sectors [1] - The "Health Examination Quality Control Specification" is the first health examination standard collaboratively developed by Beijing, Tianjin, and Hebei, focusing on quality control in health examination services [1] - The standard emphasizes comprehensive quality control throughout the health examination process, including pre-examination, during examination, and post-examination phases, enhancing service quality and safety in the region [1] Group 2 - The "Electric Vehicle Charging Infrastructure Planning and Design Standard" mandates that 100% of new residential projects must include charging infrastructure, optimizing the planning and design of charging facilities [2] - This standard aims to improve the efficiency of parking resources and charging facilities by aligning charging characteristics with travel patterns in different public building contexts [2] - The "Food Safety Management Specification for Large Events" clarifies the responsibilities of organizing units, food suppliers, and inspection agencies, providing a scientific and standardized approach to food safety management for large events in Beijing [2] Group 3 - The "Administrative Mediation Service Specification for Consumer Disputes" is the first local standard in China addressing administrative mediation for consumer disputes, detailing service requirements and processes [3] - This standard aims to enhance the efficiency of mediation services and improve the enforcement level of market regulation, contributing to a better consumer environment in Beijing [3] - The "Technical Requirements for Indoor Emergency Shelters in Primary and Secondary Schools" outlines the conversion of schools into emergency shelters without disrupting educational functions, promoting standardized emergency management practices [3]

Core Viewpoint - The health management industry in China has shown significant growth over the past two decades, with increasing market demand driven by the public's awareness and self-management of health. The market size is projected to reach 12,555.2 billion yuan in 2024 and approximately 13,225.5 billion yuan in 2025, indicating a robust growth trajectory [1][6][21]. Industry Definition and Necessity - Health management is defined as a comprehensive monitoring and evaluation of individual or group health, providing consultation and intervention to improve health levels. It originated in the late 1950s in the United States, focusing on controlling disease occurrence and reducing medical expenses [2][3][4]. Current Development Status - The health management industry in China has achieved remarkable results, with a projected market size of 12,555.2 billion yuan in 2024, and expected growth to 13,225.5 billion yuan in 2025. The demand for health management services continues to rise as public awareness increases [6][8]. Market Structure - In 2024, the health management market structure is expected to consist of 20.58% from health check-ups, 74.48% from health insurance premiums, and 4.94% from other services. By 2025, these figures are projected to shift to 21.38%, 73.18%, and 5.44%, respectively [8]. Industry Chain - The health management industry chain includes upstream suppliers of software, medical devices, and health monitoring tools, midstream health check-up institutions, and downstream health consulting services targeting individuals, corporate employees, and government agencies [10]. Development Environment and Policies - The concept of health management was introduced in China in the late 20th century, gaining traction with government initiatives like the "Healthy China 2020" strategy. Various policies have been implemented to support the development of the health management industry, emphasizing the importance of health services in economic transformation [12][14]. Competitive Landscape - The health management industry in China is characterized by intense competition, with major players including Meinian Health, Ruici Medical, and various tech companies like Xiaomi and Huawei. The market is diverse, catering to different demographic groups and health management needs [15][17]. Key Companies - Meinian Health focuses on health check-ups and integrates health consulting and intervention services, achieving a revenue of 10.702 billion yuan and a net profit of 282 million yuan in 2024 [17]. - Ruici Medical, a leading health check-up chain, reported a revenue of 2.924 billion yuan and a net profit of 297 million yuan in 2024, emphasizing customized health check-up services [19]. Development Recommendations - The health management industry should focus on building a comprehensive system that includes public hospitals, private chains, and online platforms to enhance service delivery. There is a need for specialized talent in health management, and public awareness campaigns should be intensified to promote health management practices [21][22][25].

Group 1 - The city has released 96 local standards, including 69 new and 27 revised standards, aimed at enhancing digital economy and urban safety [1][2] - The newly established "Automated Driving Map Data Exchange and Service Interface Specification" fills a gap in domestic standards for automated driving map data sharing, facilitating efficient data sharing among map providers, car manufacturers, and users [1] - The revised "Electric Vehicle Charging Infrastructure Planning and Design Standards" mandates 100% construction of charging infrastructure in new residential projects, optimizing charging facility requirements for various public buildings [2] Group 2 - The "Information Security Technology Requirements for Protection and Assessment of Important Information Infrastructure" is the first local standard in the city focusing on the security of important information infrastructure, proposing enhanced security measures [1] - The revised "Residential Property Service Standards" introduces rigid and flexible indicators for service quality, allowing homeowners to select standards based on their needs, promoting personalized property management services [2] - New standards include the first health examination quality control specification in the Beijing-Tianjin-Hebei region and the first local standard for medical security at large events [3]

Core Viewpoint - The 2025 Beijing Health Report, released by iKang Group in collaboration with the Beijing News, aims to analyze health data from nearly 1.5 million individuals who underwent health check-ups, highlighting key health issues and risks faced by Beijing residents [1][2]. Group 1: Health Status Overview - The report provides a comprehensive analysis of the health status of Beijing's population, focusing on various health risks and the prevalence of diseases such as cancer, obesity, and metabolic disorders [5][6]. - It emphasizes the importance of regular health check-ups and early detection of diseases, particularly cancer, which has seen a rising incidence among younger populations [6][12]. Group 2: Cancer Statistics - In the past year, 1,535 individuals were diagnosed with cancer among the health check-up population, indicating a cancer detection rate of 2.30 per 1,000 participants, up from 1.04 per 1,000 [6][7]. - Thyroid cancer was the most frequently detected, with a detection rate of 48%, while breast cancer cases included a notable instance of male breast cancer [6][7]. Group 3: Health Risks and Conditions - The report identifies several prevalent health issues, including obesity, with nearly 70% of male participants showing increased body mass index (BMI), and over 50% of the population suffering from osteoporosis [10][11]. - Thyroid nodules were reported in over 57% of female participants, indicating a significant health concern among women in Beijing [12][13]. Group 4: Technological Integration in Health Management - iKang Group has integrated artificial intelligence into health management, offering personalized health assessments and recommendations through its AI health manager, iKKie [17][24]. - The AI-driven approach aims to enhance the efficiency of health screenings and provide tailored health management solutions for individuals [17][24].

当招商工作插上AI羽翼，会迸发怎样的经济新动能？6月25日，黄埔区萝岗街道举办"香雪AI招商员"上线暨2025年数 智赋能载体招商会议。会上，首个街镇级招商-筹建一体化服务AI平台——"香雪AI招商员"正式上线运行，为街道范 围内31家载体提供数智化招商和入驻项目筹建服务。这一创新举措实现了招商服务从"人工筛选"到"AI智配"的跨 越，标志着萝岗街招商与企业服务工作正式迈入智能化、精准化的新阶段，为区域经济高质量发展注入新动能。 当天，包括上市公司、专精特新"小巨人"、餐饮业头部企业等在内的14家企业成功签约，总投资额超24亿元，预计 年产值（营收）达45亿元。至此，萝岗街道上半年累计签约项目23个，总投资约27亿元，预计年产值（营收）65亿 元。 从"大海捞针"到"AI秒配" "基因图谱"破题招商痛点 传统招商，常囿于信息碎片化、服务链条割裂、资源匹配低效等痛点。而"香雪AI招商员"的核心突破，正是构建了 萝岗街道全域资源的"数字孪生体"——一张动态更新的"资源基因图谱"。 这张"资源基因图谱"深度融合Deepseek大模型与本地招商31个园区载体数据库——从楼宇面积、租金梯度到配套情 况。企业只需输入需求 ...

Group 1 - The core viewpoint of the news is that Meinian Health has experienced a continuous decline in stock price, with a total drop of 7.66% over the past six days, closing at 4.94 yuan per share on June 19, with a market capitalization of 19.336 billion yuan [1] - Meinian Health's main business involves health check-ups and health management, with the revenue composition being 96.53% from check-up services and 3.47% from other services [1] - The stock has seen a trading volume of 186 million yuan and a turnover rate of 0.96% on the reporting date [1] Group 2 - According to data, a fund under China Europe Fund holds a significant position in Meinian Health, with 69,700 shares, accounting for 2.22% of the fund's net value, making it the eighth largest holding [2] - The fund has incurred a floating loss of approximately 5,576 yuan today and a total floating loss of 28,600 yuan during the six-day decline [2] - The fund manager, Song Weiwei, has a total asset scale of 6.195 billion yuan, with the best fund return during the tenure being 91.19% and the worst being -7.12% [2]

Core Viewpoint - Despite the founder's efforts to expose industry malpractices and the company's commitment to quality and customer-centric values, iKang Guobin continues to face various issues and scandals in the health examination sector [2][16]. Group 1: Company Background and Development - iKang Guobin, once known as "China's health examination first stock," was founded by Zhang Ligang, who leveraged his internet background to understand user operations and capital management, leading to a successful IPO within ten years of establishment [5]. - The company went public on NASDAQ on April 9, 2014, with an initial closing price of $15.2 per ADS, an increase of 8.57% from the offering price of $14 [7]. - However, due to a general downturn for Chinese stocks in overseas markets, iKang Guobin's stock price stagnated between $10 and $20 per ADS for several years, prompting the company to initiate privatization in August 2015 at a price of $17.8 per ADS [8][9]. Group 2: Financial Performance and Market Position - In the fiscal year 2014, iKang Guobin reported revenues of $290 million, a year-on-year increase of 43.7%, with a Non-GAAP net profit of $36.3 million, up 60.9% [10]. - In contrast, its competitor, Meinian Health, reported revenues of 6.233 billion yuan and a net profit of 614 million yuan in 2017, significantly lower than iKang Guobin's figures at that time [10]. - As of November 2024, iKang Guobin operates 173 health examination centers across 57 cities, showing limited growth with an average increase of only 10 centers per year since 2018 [12]. Group 3: Industry Challenges and Issues - The health examination industry in China has faced numerous scandals, including sample mix-ups and data errors, leading to a lack of standardized operations [16]. - Zhang Ligang publicly exposed these issues at the China Enterprise Leaders Annual Conference in December 2018, highlighting severe malpractice within the industry [16]. - Despite the company's stated values of quality and customer trust, iKang Guobin continues to encounter various operational problems, undermining its credibility [2][16].

特别提示： 日披露的《美年大健康产业控股股份有限公司发行股份购买资产暨关联交易预案》 "重大事项提示"及"重大风险提示"章节中，详细披露了公司拟发行股份购买资产 （以下简称"本次交易"）可能存在的风险因素及尚需履行的其他程序，敬请广大 投资者注意投资风险。 买资产暨关联交易预案》披露的风险因素外，公司尚未发现可能导致本次交易中 止、取消或者对本次交易方案作出实质性变更的相关事项，本次交易工作正在有 序进行中。 证券代码：002044 证券简称：美年健康 公告编号：2025-034 公司拟通过发行股份的方式购买交易对方持有的衡阳美年健康体检中心有 限公司 84.00%股权、宁德美年大健康管理有限公司 81.00%股权、烟台美年大健 康体检管理有限公司 75.00%股权、烟台美年福田健康体检管理有限公司 49.00% 股权、武汉美慈奥亚科技管理有限公司 52.81%股权、三明美年大健康管理有限 公司 85.00%股权、肥城美年健康管理有限公司 90.00%股权、南宁美元康健康管 理有限公司 69.86%股权、德州美年大健康体检管理有限公司 84.00%股权、安溪 美年大健康管理有限公司 72.90%股权、连江美年 ...